X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (202) 202
index medicus (181) 181
animals (167) 167
reassortant viruses - genetics (128) 128
viruses (122) 122
virology (108) 108
immunology (79) 79
infectious diseases (77) 77
virus diseases (68) 68
influenza (64) 64
analysis (61) 61
microbiology (58) 58
infection (55) 55
phylogeny (55) 55
reassortant viruses - drug effects (53) 53
vaccines (52) 52
reassortant viruses - immunology (51) 51
female (49) 49
health aspects (46) 46
molecular sequence data (45) 45
avian influenza (43) 43
reassortant viruses (42) 42
influenza, human - virology (41) 41
mice (41) 41
research (40) 40
antiviral agents - pharmacology (39) 39
mutation (39) 39
vaccination (38) 38
cell line (36) 36
medicine, research & experimental (35) 35
a virus (34) 34
pandemics (34) 34
virulence (34) 34
article (33) 33
evolution (33) 33
hemagglutinin (33) 33
genotype (32) 32
hiv-1 - genetics (31) 31
genetic aspects (30) 30
influenza vaccines - immunology (30) 30
multidisciplinary sciences (30) 30
reassortant viruses - pathogenicity (30) 30
research article (30) 30
dogs (29) 29
genome, viral (29) 29
infections (29) 29
influenza in birds - virology (29) 29
reassortant viruses - isolation & purification (29) 29
male (28) 28
poultry (28) 28
viral proteins - genetics (28) 28
amino acid sequence (27) 27
medicine (27) 27
reassortant viruses - physiology (27) 27
virus replication (27) 27
epidemics (26) 26
genomes (26) 26
influenza a virus, h1n1 subtype - genetics (26) 26
immunogenicity (25) 25
influenza a virus - genetics (25) 25
influenza, human - epidemiology (25) 25
orthomyxoviridae infections - virology (25) 25
safety (25) 25
hiv (24) 24
immunization (24) 24
infant (24) 24
influenza vaccines (24) 24
influenza viruses (24) 24
replication (24) 24
sequence analysis, dna (24) 24
antiviral agents (23) 23
pharmacology & pharmacy (23) 23
reassortant (23) 23
reassortant viruses - classification (23) 23
rotavirus infections - prevention & control (23) 23
vaccine (23) 23
avian influenza viruses (22) 22
influenza, human - prevention & control (22) 22
proteins (22) 22
efficacy (21) 21
genes (21) 21
influenza a virus, h5n1 subtype - genetics (21) 21
recombination, genetic (21) 21
rna, viral - genetics (21) 21
rotavirus - immunology (21) 21
transmission (21) 21
virus replication - drug effects (21) 21
adult (20) 20
allergy and immunology (20) 20
children (20) 20
diarrhea (20) 20
hiv infections - virology (20) 20
hong-kong (20) 20
mice, inbred balb c (20) 20
vaccines, attenuated - immunology (20) 20
hemagglutinin glycoproteins, influenza virus - genetics (19) 19
influenza in birds - epidemiology (19) 19
medical microbiology (19) 19
reassortant viruses - growth & development (19) 19
science (19) 19
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2016, Volume 60, Issue 11, pp. 6679 - 6691
T-705 (favipiravir) is a new antiviral agent in advanced clinical development for influenza therapy. It is supposed to act as an alternative substrate for the... 
NUCLEOTIDE POOL | IN-VITRO | NEURAMINIDASE INHIBITORS | MECHANISM | TRANSCRIPTION | BIOLOGICAL EVALUATION | POLYMERASE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | ANTIVIRAL AGENT | LETHAL MUTAGENESIS | DNA-Directed RNA Polymerases - antagonists & inhibitors | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Influenza A Virus, H3N2 Subtype - metabolism | Reassortant Viruses - genetics | Reassortant Viruses - drug effects | Structure-Activity Relationship | Influenza A Virus, H3N2 Subtype - genetics | IMP Dehydrogenase - genetics | Influenza A Virus, H1N1 Subtype - growth & development | Viral Proteins - metabolism | Influenza A Virus, H3N2 Subtype - growth & development | RNA, Viral - antagonists & inhibitors | Antiviral Agents - chemistry | Madin Darby Canine Kidney Cells | Influenza A Virus, H1N1 Subtype - genetics | Influenza A Virus, H1N1 Subtype - metabolism | Amides - pharmacology | A549 Cells | Virus Replication - drug effects | Antiviral Agents - pharmacology | Reassortant Viruses - metabolism | RNA, Viral - biosynthesis | Viral Proteins - genetics | Viral Proteins - antagonists & inhibitors | DNA-Directed RNA Polymerases - genetics | Ribavirin - chemistry | Influenza A Virus, H1N1 Subtype - drug effects | Chick Embryo | Reassortant Viruses - growth & development | IMP Dehydrogenase - metabolism | Pyrazines - chemistry | Animals | Mutation - drug effects | Sequence Analysis, RNA | IMP Dehydrogenase - antagonists & inhibitors | Gene Expression Regulation, Viral | Dogs | Amides - chemistry | DNA-Directed RNA Polymerases - metabolism | Pyrazines - pharmacology | Ribavirin - pharmacology
Journal Article
Journal of Virology, ISSN 0022-538X, 08/2011, Volume 85, Issue 16, pp. 8413 - 8421
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0159332
Women need multipurpose prevention products (MPTs) that protect against sexually transmitted infections (STIs) and provide contraception. The Population... 
WOMEN | IN-VITRO | PHARMACOKINETICS | HIV ACQUISITION | MULTIDISCIPLINARY SCIENCES | PREVENTION | REVERSE-TRANSCRIPTASE INFECTION | PHARMACODYNAMICS | CONTRACEPTIVES | GEL | HPV | Contraceptive Agents, Female - pharmacology | Vagina - drug effects | Anti-Infective Agents - pharmacology | Reassortant Viruses - genetics | Reverse Transcriptase Inhibitors - pharmacology | Simian Immunodeficiency Virus - growth & development | Reassortant Viruses - drug effects | Macaca mulatta | HIV - drug effects | Simian Immunodeficiency Virus - genetics | Carrageenan - pharmacology | Urea - analogs & derivatives | Female | Mucous Membrane - drug effects | Levonorgestrel - pharmacology | Mucous Membrane - virology | Contraceptive Devices, Female | Treatment Outcome | HIV - growth & development | Reassortant Viruses - growth & development | Animals | Zinc Acetate - pharmacology | Vagina - virology | HIV - genetics | Pyridines - pharmacology | Simian Immunodeficiency Virus - drug effects | Drug Combinations | Urea - pharmacology | Women | Anti-infective agents | Care and treatment | HIV infection | Health aspects | Analysis | Health care | Sexually transmitted diseases--STD | RNA-directed DNA polymerase | Mucosa | Infections | Tissues | Prevention | Reproduction | Human papillomavirus | Acquired immune deficiency syndrome--AIDS | Compartments | Human immunodeficiency virus--HIV | Inhibition | Zinc acetate | Enzyme-linked immunosorbent assay | Reproductive systems | Computational fluid dynamics | Vagina | Contraception | Cervix | Zinc | Pregnancy | Studies | Carrageenan | Acetic acid | STD | Sexually transmitted diseases | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
Journal Article
Archives of Virology, ISSN 0304-8608, 2/2017, Volume 162, Issue 2, pp. 457 - 467
Journal Article